Progress in treatment of childhood acute myeloid leukemia

  • WU Jun ,
  • ZHANG Leping
Expand
  • 1 .Department of Pediatrics, Peking University Shougang Hospital, Beijing 100144 , China; 2 .Department of Pediatrics, People’s Hospital, Peking University, Beijing 100144, China

Online published: 2021-09-03

Abstract

Acute myeloid leukemia (AML) is a malignant clonal disease in which abnormal bone marrow hematopoietic precursor cells accumulate due to differentiation disorder and excessive proliferation of the hematopoietic stem cells. In recent years, with the rational application of risk stratification, continuous research and development of the targeted drugs, advancement of supportive treatments and maturity of the hematopoietic stem cell transplantation technology, the survival rate of pediatric AML has been significantly improved. This article reviews the progress in the treatment of pediatric AML.

Cite this article

WU Jun , ZHANG Leping . Progress in treatment of childhood acute myeloid leukemia[J]. Journal of Clinical Pediatrics, 2021 , 39(9) : 715 . DOI: 10.3969/j.issn.1000-3606.2021.09.018

Outlines

/